Literature DB >> 24635555

Topical delivery of ocular therapeutics: carrier systems and physical methods.

Joel G Souza1, Karina Dias, Tatiana Aparecida Pereira, Daniela Spuri Bernardi, Renata F V Lopez.   

Abstract

OBJECTIVE: The basic concepts, major mechanisms, technological developments and advantages of the topical application of lipid-based systems (microemulsions, nanoemulsions, liposomes and solid lipid nanoparticles), polymeric systems (hydrogels, contact lenses, polymeric nanoparticles and dendrimers) and physical methods (iontophoresis and sonophoresis) will be reviewed. KEY
FINDINGS: Although very convenient for patients, topical administration of conventional drug formulations for the treatment of eye diseases requires high drug doses, frequent administration and rarely provides high drug bioavailability. Thus, strategies to improve the efficacy of topical treatments have been extensively investigated. In general, the majority of the successful delivery systems are present on the ocular surface over an extended period of time, and these systems typically improve drug bioavailability in the anterior chamber whereas the physical methods facilitate drug penetration over a very short period of time through ocular barriers, such as the cornea and sclera.
SUMMARY: Although in the early stages, the combination of these delivery systems with physical methods would appear to be a promising tool to decrease the dose and frequency of administration; thereby, patient compliance and treatment efficacy will be improved.
© 2013 Royal Pharmaceutical Society.

Entities:  

Keywords:  contact lens; dendrimers; iontophoresis; nanoparticle; topical ocular delivery

Mesh:

Substances:

Year:  2013        PMID: 24635555     DOI: 10.1111/jphp.12132

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  18 in total

Review 1.  Single compartment drug delivery.

Authors:  Michael J Cima; Heejin Lee; Karen Daniel; Laura M Tanenbaum; Aikaterini Mantzavinou; Kevin C Spencer; Qunya Ong; Jay C Sy; John Santini; Carl M Schoellhammer; Daniel Blankschtein; Robert S Langer
Journal:  J Control Release       Date:  2014-05-04       Impact factor: 9.776

2.  Ex vivo rabbit cornea diffusion studies with a soluble insert of moxifloxacin.

Authors:  María Sebastián-Morelló; María Aracely Calatayud-Pascual; Vicent Rodilla; Cristina Balaguer-Fernández; Alicia López-Castellano
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 3.  Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective.

Authors:  Krista M Cosert; Soohyun Kim; Iman Jalilian; Maggie Chang; Brooke L Gates; Kent E Pinkerton; Laura S Van Winkle; Vijay Krishna Raghunathan; Brian C Leonard; Sara M Thomasy
Journal:  Pharmaceutics       Date:  2022-05-03       Impact factor: 6.525

4.  Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure.

Authors:  Wendi S Lambert; Brian J Carlson; Alice E van der Ende; Grace Shih; Julia N Dobish; David J Calkins; Eva Harth
Journal:  Transl Vis Sci Technol       Date:  2015-01-13       Impact factor: 3.283

5.  Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.

Authors:  Shuai Shi; Zhaoliang Zhang; Zichao Luo; Jing Yu; Renlong Liang; Xingyi Li; Hao Chen
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

Review 6.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30

7.  Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.

Authors:  Elshaimaa G Sayed; Amal K Hussein; Khaled A Khaled; Osama A A Ahmed
Journal:  Drug Des Devel Ther       Date:  2015-03-10       Impact factor: 4.162

8.  Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.

Authors:  Dinesh Jaishankar; Jason S Buhrman; Tibor Valyi-Nagy; Richard A Gemeinhart; Deepak Shukla
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-01-01       Impact factor: 4.799

Review 9.  Relevance of Lipid-Based Products in the Management of Dry Eye Disease.

Authors:  Jean-Sébastien Garrigue; Mourad Amrane; Marie-Odile Faure; Juha M Holopainen; Louis Tong
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-28       Impact factor: 2.671

Review 10.  Advanced drug delivery and targeting technologies for the ocular diseases.

Authors:  Jaleh Barar; Ayuob Aghanejad; Marziyeh Fathi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.